- Home
- ABM vs SUPN Comparison
ABM vs SUPN Comparison
Compare ABM & SUPN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ABM
- SUPN
- Stock Information
- Founded
- ABM 1909
- SUPN 2005
- Country
- ABM United States
- SUPN United States
- Employees
- ABM N/A
- SUPN N/A
- Industry
- ABM Diversified Commercial Services
- SUPN Biotechnology: Pharmaceutical Preparations
- Sector
- ABM Finance
- SUPN Health Care
- Exchange
- ABM Nasdaq
- SUPN Nasdaq
- Market Cap
- ABM 2.8B
- SUPN 2.6B
- IPO Year
- ABM N/A
- SUPN 2012
- Fundamental
- Price
- ABM $45.60
- SUPN $47.92
- Analyst Decision
- ABM Strong Buy
- SUPN Buy
- Analyst Count
- ABM 3
- SUPN 2
- Target Price
- ABM $55.67
- SUPN $51.50
- AVG Volume (30 Days)
- ABM 544.7K
- SUPN 682.2K
- Earning Date
- ABM 09-05-2025
- SUPN 11-03-2025
- Dividend Yield
- ABM 2.32%
- SUPN N/A
- EPS Growth
- ABM N/A
- SUPN 1411.53
- EPS
- ABM 1.84
- SUPN 1.14
- Revenue
- ABM $8,627,900,000.00
- SUPN $665,125,000.00
- Revenue This Year
- ABM $5.43
- SUPN $6.71
- Revenue Next Year
- ABM $3.15
- SUPN $19.74
- P/E Ratio
- ABM $24.82
- SUPN $42.23
- Revenue Growth
- ABM 4.27
- SUPN 5.55
- 52 Week Low
- ABM $40.85
- SUPN $29.16
- 52 Week High
- ABM $59.15
- SUPN $49.66
- Technical
- Relative Strength Index (RSI)
- ABM 42.52
- SUPN 66.02
- Support Level
- ABM $44.56
- SUPN $47.34
- Resistance Level
- ABM $47.16
- SUPN $49.66
- Average True Range (ATR)
- ABM 0.92
- SUPN 1.23
- MACD
- ABM 0.08
- SUPN -0.08
- Stochastic Oscillator
- ABM 36.92
- SUPN 66.70
About ABM ABM Industries Incorporated
ABM Industries Inc is a provider of integrated facility solutions. It offers its solutions through five segments: Business and Industry, Manufacturing and Distribution, Education, Aviation and Technical solutions. The company derives the majority of its revenue from the business and industry segment, which encompasses janitorial, facilities engineering, and parking services for commercial real estate properties and sports and entertainment venues, hospitals, as well as vehicle maintenance and other services to rental car providers. The company mainly operates in the United States of America.
About SUPN Supernus Pharmaceuticals Inc.
Supernus Pharmaceuticals Inc is a specialty pharmaceutical company. The company is engaged in developing and commercializing products for the treatment of central nervous system diseases, including neurological and psychiatric disorders. Its diverse neuroscience portfolio includes approved treatments for epilepsy, migraine, attention-deficit hyperactivity disorder (ADHD), hypomobility in Parkinson's Disease (PD), cervical dystonia, chronic sialorrhea, dyskinesia in PD patients receiving levodopa-based therapy, and drug-induced extrapyramidal reactions in adult patients. The company's products include Trokendi XR, Oxtellar XR, Qelbree, APOKYN, XADAGO, MYOBLOC, GOCOVRI, and Osmolex ER.